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PCardiac Imaging
Prognostic Value of Multislice Computed
Tomography Coronary Angiography in Patients
With Known or Suspected Coronary Artery Disease
Gabija Pundziute, MD,*† Joanne D. Schuijf, MSC,*‡ J. Wouter Jukema, MD, PHD,*‡
Eric Boersma, PHD,§ Albert de Roos, MD, PHD, Ernst E. van der Wall, MD, PHD,*‡
Jeroen J. Bax, MD, PHD*
Leiden, Utrecht, and Rotterdam, the Netherlands; and Kaunas, Lithuania
Objectives This study sought to determine the prognostic value of multislice computed tomography (MSCT) coronary an-
giography in patients with known or suspected coronary artery disease (CAD).
Background It is expected that MSCT will be used increasingly as an alternative imaging modality in the diagnosis of patients
with suspected CAD. Data on the prognostic value of MSCT, however, are currently not available.
Methods A total of 100 patients (73 men, age 59  12 years) who were referred for further cardiac evaluation due to
suspicion of significant CAD underwent additional MSCT coronary angiography to evaluate the presence and se-
verity of CAD. Patients were followed up for the occurrence of: 1) cardiac death, 2) nonfatal myocardial infarc-
tion, 3) unstable angina requiring hospitalization, and 4) revascularization.
Results Coronary plaques were detected in 80 (80%) patients. During a mean follow-up of 16 months, 33 events oc-
curred in 26 patients. In patients with normal coronary arteries on MSCT, the first-year event rate was 0% versus
30% in patients with any evidence of CAD on MSCT. The observed event rate was highest in the presence of ob-
structive lesions (63%) and when obstructive lesions were located in the left main (LM)/left anterior descending
(LAD) coronary arteries (77%). Nonetheless, an elevated event rate was also observed in patients with nonob-
structive CAD (8%). In multivariate analysis, significant predictors of events were the presence of CAD, obstruc-
tive CAD, obstructive CAD in LM/LAD, number of segments with plaques, number of segments with obstructive
plaques, and number of segments with mixed plaques.
Conclusions Multislice computed tomography coronary angiography provides independent prognostic information over base-
line clinical risk factors in patients with known and suspected CAD. An excellent prognosis was noted in patients
with a normal MSCT. (J Am Coll Cardiol 2007;49:62–70) © 2007 by the American College of Cardiology
Foundation
ublished by Elsevier Inc. doi:10.1016/j.jacc.2006.07.070(
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cn patients presenting with suspected or known coronary artery
isease (CAD), assessment of prognosis is essential in selecting
ppropriate patient management. Currently, extensive data are
vailable on the prognostic value of myocardial perfusion
maging with single-photon emission computed tomography
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etherlands; †Department of Cardiology, Kaunas University of Medicine, Kaunas,
ithuania; ‡Interuniversity Cardiology Institute of the Netherlands, Utrecht, the
etherlands; §Department of Epidemiology and Statistics, Erasmus University,
otterdam, the Netherlands; and the Department of Radiology, Leiden University
edical Center, Leiden, the Netherlands. Supported by the Training Fellowship of
he European Society of Cardiology and the Huygens scholarship, the Hague, the
etherlands (Dr. Pundziute) and The Netherlands Heart Foundation, the Hague, the
etherlands, grant 2002B105 (Dr. Schuijf). Drs. Pundziute and Schuijf contributed
qually to this article and are shared first authors. Frank Bengel, MD, served as the
uest Editor for this article.m
Manuscript received May 1, 2006; revised manuscript received July 24, 2006,
ccepted July 27, 2006.SPECT). A normal SPECT study has been shown to indicate
good clinical outcome with an annual death or infarct rate of
1% per year, whereas the likelihood to develop cardiac events
s significantly increased when perfusion abnormalities are
etected (1,2). Similarly, coronary artery calcium score assessed
y electron beam computed tomography (EBCT) or, less
requently, by multislice computed tomography (MSCT), has
een used for risk stratification in patients with known or
uspected CAD, and a calcium score100 has been associated
ith excellent outcome, with an increase in the event rate
aralleling the increase in calcium score (3,4).
More recently, noninvasive coronary angiography tech-
iques (magnetic resonance imaging, EBCT, and MSCT)
ave been introduced which allow direct visualization of
oronary artery lesions. At present, MSCT appears to be the
ost robust technique for this purpose, and it is expected
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January 2/9, 2007:62–70 Prognostic Value of MSCT Coronary Angiographyhat this technique will be increasingly used as an alternative
rst-line imaging modality in the diagnosis of patients
resenting with chest pain suspect for CAD. Multislice
omputed tomography allows detection of both obstructive
nd nonobstructive lesions, and noncalcified lesions are also
isualized. Although the diagnostic accuracy of MSCT has
een demonstrated, data on the prognostic value of MSCT
re not available. Accordingly, the aim of this study was to
etermine the prognostic value of MSCT in patients with
nown or suspected CAD.
ethods
atients and study protocol. The study population con-
isted of consecutive patients who presented to the outpa-
ient clinic and were referred for further evaluation (using
xercise electrocardiogram, perfusion imaging, or invasive
oronary angiography) of suspected CAD (chest pain com-
laints, elevated risk profile, or abnormal test results). In all
atients, MSCT coronary angiography was performed in
ddition to the standard clinical workup. Subsequent clini-
al management was based on the latter; MSCT findings
ere not included in the diagnostic/therapeutic workup.
Only patients without previous coronary bypass grafting
ho were in sinus rhythm and without contraindications to
odinated contrast media were included, resulting in the
xclusion of 5 patients because of potential contrast allergy
n  3) and atrial fibrillation (n  2), respectively. Follow-up
as successful in all patients. All patients gave written
nformed consent to the study protocol, which was approved
y the local ethics committee.
A structured interview and clinical history were acquired,
nd the following cardiac risk factors were assessed before
he MSCT examination: 1) diabetes mellitus (defined as a
asting glucose level of7 mmol/l or the need for insulin or
ral hypoglycemic agents) (5); 2) hypercholesterolemia (de-
ned as a total cholesterol level 5 mmol/l or treatment
ith lipid-lowering drugs) (6); 3) hypertension (defined as
lood pressure 140/90 mm Hg or the use of antihyper-
ensive medication) (7); 4) obesity (body mass index 30
g/m2) (8); 5) positive family history of CAD (defined as
he presence of CAD in first-degree relatives younger than
5 [male] or 65 [female] years of age) (9); and 6) smoking
defined as previous or current smoking).
SCT data acquisition. All examinations were performed
sing Toshiba Multislice Aquilion systems (Toshiba Med-
cal Systems, Tokyo, Japan). If the heart rate was 65
eats/min, additional oral beta-blockers (metoprolol, 50
g, single dose, 1 h before scan) were provided if tolerated.
irst, a prospectively triggered coronary calcium scan was
erformed before MSCT angiography with identical pa-
ameters for 16- and 64-slice MSCT systems: collimation
 3.0 mm, gantry rotation time 500 ms, tube voltage and
ube current 120 kV and 200 mA, respectively. The tem-
oral window was set at 75% after the R-wave for electro-
ardiographically triggered prospective reconstruction. wSixteen-slice MSCT coronary
ngiography was performed ac-
ording to the protocol described
lsewhere (10). The following pa-
ameters were applied for 64-slice
SCT coronary angiography:
ollimation of 64  0.5 mm; tube
otation time of 400, 450, or 500
s, depending on the heart rate;
ube current 300 mA at 120 kV.
onionic contrast material was
dministered in the antecubital
ein with an amount of 80 to 105
l, depending on the total scan
ime, and a flow rate of 5 ml/s
Iomeron 400, Bracco Altana
harma, Konstanz, Germany). Automated detection of peak
nhancement in the aortic root was used for timing of the scan.
ll images were acquired during an inspiratory breath hold of
pproximately 10 s, with simultaneous registration of the
atient’s electrocardiogram. With the aid of a segmental
econstruction algorithm, data of 1, 2, or 3 consecutive heart-
eats were used to generate a single image.
To evaluate the presence of coronary artery plaques,
econstructions in diastole (typically 75% of the cardiac
ycle) were generated with a slice thickness of 0.5 mm at an
ncrement of 0.3 mm. If motion artefacts were present,
dditional reconstructions were made in different time
oints of the R-R interval. Axial data sets were transferred
o a remote workstation (Vitrea 2, Vital Images, Plymouth,
innesota) for postprocessing and subsequent evaluation.
SCT data analysis. CORONARY ARTERY CALCIUM SCORE.
he coronary artery calcium score was assessed with the
pplication of dedicated software (Vitrea 2). Coronary artery
alcium was identified as a dense area in the coronary artery
xceeding the threshold of 130 HU. An overall Agatston
core was recorded for each patient.
ORONARY PLAQUE ASSESSMENT. For the current study, all
SCT angiograms were evaluated within a time frame of 2
eeks by 2 experienced observers unaware of the clinical
istory of the patients, using a standard analysis (see later
ext). In case of disagreement, a joint reading was performed
nd a consensus decision was reached. Coronary arteries
ere divided into 17 segments according to the modified
merican Heart Association classification (11). Only seg-
ents with a diameter 1.5 mm (as measured on the
SCT coronary angiogram) were included. First, each
egment was classified as interpretable or not. Predefined,
atients were excluded from the analysis in case of: 1) an
ninterpretable proximal or mid segment, or 2) more than 3
ninterpretable segments in general.
Then, the interpretable segments were evaluated for the
resence of any atherosclerotic plaque using axial images
nd curved multiplanar reconstructions. Coronary plaques
Abbreviations
and Acronyms
CAD  coronary artery
disease
EBCT  electron beam
computed tomography
LAD  left anterior
descending coronary artery
LM  left main coronary
artery
MSCT  multislice
computed tomography
SPECT  single-photon
emission computed
tomographyere defined as structures 1 mm2 within and/or adjacent
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Prognostic Value of MSCT Coronary Angiography January 2/9, 2007:62–70o the coronary artery lumen, which could be clearly
istinguished from the vessel lumen and the surrounding
ericardial tissue, as previously described (12). One coronary
laque was assigned per coronary segment. Subsequently,
he type of plaque was determined using the following
lassification: 1) noncalcified plaques, plaques having lower
ensity compared with the contrast-enhanced vessel lumen;
) calcified plaques, plaques with high density; and 3) mixed
laques, plaques with noncalcified and calcified elements
ithin a single plaque. Finally, it was determined whether
he lesion was obstructive or not, using a threshold of 50%
uminal narrowing. For each patient, the number of diseased
oronary segments, number of segments with obstructive
esions, and number of each type of plaque was calculated.
atients without coronary artery calcium or coronary
laques on MSCT were considered normal; an abnormal
SCT was defined in the presence of 1 coronary plaque.
bnormal patients were further classified as having obstruc-
ive coronary plaques (50% luminal narrowing) in 1 or
ore coronary arteries, as well as having obstructive coro-
ary lesions in the left main (LM) and/or left anterior
escending (LAD) coronary arteries.
ollow-up. Follow-up information was obtained by either
linical visits or telephone interviews. Hospital records of all
atients were screened for the occurrence of clinical events to
onfirm the obtained information. Clinical end points were the
ccurrence of: 1) cardiac death, 2) nonfatal infarction, 3)
nstable angina requiring hospitalization, or 4) revasculariza-
ion. Cardiac death was defined as death caused by acute
Characteristics of the Study Population andomparison Between Patients With and Withou
Table 1 Characteristics of the Study PopulaComparison Between Patients With
All Patients
(n  100)
n (%)
Clinical characteristics
Age (yrs)* (mean  SD) 59  12
Male gender 73 (73)
Obesity 20 (20)
Diabetes 21 (21)
Hypercholesterolemia 50 (50)
Hypertension 44 (44)
Family history of CAD 42 (42)
Smoking 39 (39)
EuroSCORE value* (mean  SD) 2.4  2.2
Cardiac history
Suspected CAD 65 (65)
Previous MI 33 (33)
Previous revascularization 31 (31)
Medical therapy
ACE inhibitors 37 (37)
Nitrates 14 (14)
Beta-blockers 56 (56)
Aspirin 54 (54)
Statins 50 (50)
*p  0.05 between patients with and without events.
ACE  angiotensin-converting enzyme; CAD  coronary artery disease; Eu
MI  myocardial infarction.yocardial infarction, ventricular arrhythmias, or refractory
eart failure. Nonfatal myocardial infarction was defined based
n criteria of typical chest pain, elevated cardiac enzyme levels,
nd typical changes on the electrocardiogram (13).
tatistical analysis. Categorical baseline characteristics are
xpressed as numbers and percentages, and compared be-
ween 2 groups with the chi-square test. Continuous vari-
bles are expressed as mean (standard deviation) and com-
ared with the 2-tailed t test for independent samples.
hen not normally distributed, continuous variables are
xpressed as medians (25th to 75th percentile range) and
ompared using a nonparametric Mann-Whitney test.
To identify the association between MSCT variables and
utcomes, Cox regression analysis was used. A composite
nd point of cardiac death, nonfatal infarction, unstable
ngina requiring hospitalization, and revascularization was
sed. First, univariate analysis of baseline clinical character-
stics and MSCT variables was performed to identify
otential predictors. Hazard ratios were calculated with 95%
onfidence intervals as an estimate of the risk associated
ith a particular variable. To determine independent pre-
ictors of the composite end point, multivariate analysis of
SCT variables with p  0.05 in the univariate analysis
as performed, which was corrected for the baseline char-
cteristics with p  0.5 in the univariate analysis.
Cumulative event rates as a function over time were
btained by the Kaplan-Meier method. Event curves of the
omposite end point (cardiac death, nonfatal infarction,
nstable angina requiring hospitalization, revascularization)
nts
and
Without Events
Patients With Events
(n  26)
n (%)
Patients Without Events
(n  74)
n (%)
63  10 58  12
20 (77) 53 (72)
4 (18) 16 (22)
5 (19) 16 (22)
15 (58) 35 (47)
9 (35) 35 (47)
12 (46) 30 (41)
13 (50) 26 (35)
3.4  2.5 2.1  2
14 (54) 51 (65)
11 (42) 22 (30)
10 (39) 21 (28)
7 (27) 30 (41)
4 (15) 10 (14)
16 (62) 40 (54)
17 (65) 37 (50)
12 (46) 38 (51)t Eve
tion
androSCORE  European System for Cardiac Operative Risk Evaluation;
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January 2/9, 2007:62–70 Prognostic Value of MSCT Coronary Angiographynd hard cardiac events (cardiac death, nonfatal infarction,
nd unstable angina requiring hospitalization) were com-
ared using the log-rank test.
Statistical analyses were performed using SPSS software
version 12.0, SPSS Inc., Chicago, Illinois) and SAS software
version 6.12, SAS Institute Inc., Cary, North Carolina), and
values  0.05 were considered statistically significant.
esults
atient characteristics. In total, 104 consecutive patients
ere enrolled in the present study. In 4 patients, an elevated
Figure 1 Examples of Different Multislice Computed Tomograp
(A, B, C) Curved multiplanar reconstructions of, respectively, the left anterior desc
(RCA) of a patient with normal coronary arteries are provided. (D) Curved multiplan
out obstructive lesions. (E) Stenosis of the left main coronary artery as well as pr
SCT Characteristics of the Study Population and Comparison Bet
Table 2 MSCT Characteristics of the Study Population and Com
Total Agatston score,* median (25th to 75th percentile)
Coronary plaques on MSCT,* n (%)
Obstructive CAD,* n (%)
Obstructive CAD in LM/LAD,* n (%)
Segments with plaques,* median (25th to 75th percentile)
Segments with obstructive plaques,* median (25th to 75th percentile)
Segments with noncalcified plaques, median (25th to 75th percentile)
Segments with mixed plaques,* median (25th to 75th percentile)
Segments with calcified plaques,* median (25th to 75th percentile)
p  0.05 between patients with and without events.
CAD  coronary artery disease; LAD  left anterior descending coronary artery; LM  left mainnd/or irregular heart rate during MSCT data acquisition
endered the MSCT data set uninterpretable, and these
atients were excluded from the analysis. As a result, 100
atients (73 men, mean age 59 12 years) were included in
he study (15 patients were included in a previous study on
he diagnostic accuracy of MSCT in direct comparison with
nvasive angiography [10]). Baseline characteristics are pro-
ided in Table 1. Briefly, 65 patients (65%) presented with
uspected CAD at the time of MSCT, whereas CAD was
nown in the remaining 35 patients (35%) (33 patients had
revious myocardial infarction, 31 patients had previous
servations
g coronary artery (LAD), left circumflex coronary artery, and right coronary artery
onstruction of the RCA is provided, showing diffuse coronary artery disease with-
LAD can be observed.
Patients With and Without Events
son Between Patients With and Without Events
tients
100)
Patients With Events
(n  26)
Patients Without Events
(n  74)
–383) 311 (122–552) 62 (0–309)
0%) 26 (100%) 54 (73%)
2%) 20 (77%) 12 (16%)
3%) 18 (69%) 5 (7%)
–5) 5 (4–7) 2 (0–5)
–1) 1.5 (0.8–3) 0
–1) 0 (0–1) 0 (0–1)
–2) 2 (0.8–3.3) 0 (0–2)
–3) 2.5 (1–4) 1 (0–3)
ry artery; MSCT  multislice computed tomography.hy Ob
endin
ar rec
oximalween
pari
All Pa
(n 
147 (0
80 (8
32 (3
23 (2
3 (1
0 (0
0 (0
0 (0
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Prognostic Value of MSCT Coronary Angiography January 2/9, 2007:62–70ercutaneous coronary intervention). In total, 55 patients
nderwent 16-slice MSCT and 45 underwent 64-slice
SCT.
SCT. The MSCT characteristics are provided in Table
. Only coronary segments with sufficient lumen diameter
or evaluation of the presence of plaques were included in
he analysis. After exclusion of 33 (2%) coronary segments
ith stents and 19 (1%) nonevaluable segments because of
otion artifacts, plaque burden was evaluated in 1,298
egments. CAD was completely absent in 20 patients. In
he remaining 80 patients, 345 coronary segments with
laques were observed, of which 47 (14%) contained non-
alcified plaques, 109 (31%) mixed plaques, and 189 (55%)
alcified plaques. In 71 (21%) segments of 32 (32%)
atients, plaques were regarded as obstructive (50% luminal
arrowing). Thirty-two (9%) segments with obstructive lesions
n 23 (23%) patients were located in the LM and/or LAD
nivariate Predictors of Events
Table 3 Univariate Predictors of Events
HR (95% CI) p Value
Clinical characteristics
Age (yrs) 1.0 (0.99–1.0) 0.12
Male gender 0.86 (0.34–2.2) 0.75
Obesity 0.71 (0.24–2.0) 0.52
Diabetes 0.85 (0.32–2.3) 0.74
Hypercholesterolemia 1.4 (0.62–3.0) 0.45
Hypertension 0.62 (0.28–1.3) 0.24
Family history of CAD 1.3 (0.61–2.9) 0.47
Smoking 1.7 (0.77–3.6) 0.19
Previous revascularization 1.4 (0.62–3.1) 0.63
Previous infarction 1.5 (0.67–3.2) 0.92
EuroSCORE value 1.1 (0.99–1.3) 0.08
Medical therapy
ACE inhibitors 0.65 (0.28–1.6) 0.34
Nitrates 1.0 (0.36–3.0) 0.94
Beta-blockers 1.4 (0.61–3.0) 0.46
Aspirin 1.8 (0.80–4.0) 0.15
Statins 0.86 (0.40–1.9) 0.70
MSCT characteristics
Total Agatston score 1.1 (1.0–1.1) 0.06
Presence of coronary plaques on MSCT 8.0 (1.1–59) 0.04
Abnormal coronary arteries, no obstructive
CAD (as compared with no CAD)
2.7 (0.32–22) 0.36
Abnormal coronary arteries, obstructive
CAD (as compared with no CAD)
22 (2.9–166) 0.003
Abnormal coronary arteries, no obstructive
CAD in LM/LAD
3.1 (0.39–25) 0.29
Abnormal coronary arteries, obstructive
CAD in LM/LAD
36 (4.7–276) 0.0006
Segments with plaques* 1.3 (1.1–1.4) 0.0005
Segments with obstructive plaques* 1.8 (1.5–2.1) 0.0001
Segments with noncalcified plaques* 1.1 (0.78–1.6) 0.43
Segments with mixed plaques* 1.5 (1.3–1.9) 0.0002
Segments with calcified plaques* 1.1 (0.98–1.3) 0.1
Ratio per segment.
CI  confidence interval; HR  hazard ratio; other abbreviations as in Tables 1 and 2.oronary artery. In Figure 1, examples of different MSCT
Dbservations, including normal coronary arteries, nonobstruc-
ive CAD, and obstructive CAD in the LM, are shown.
ollow-up results. During a mean follow-up of 16 months
median 13 months, interquartile range 5 to 39 months), 33
vents occurred in 26 patients (with 7 events occurring
epeatedly). One patient (1%) died of acute myocardial
nfarction. Nonfatal myocardial infarction occurred in 3
atients (3%), and unstable angina requiring hospitalization
ccurred in 4 patients (4%, with 1 also undergoing revas-
ularization). A total of 24 patients (24%) underwent
oronary revascularization; percutaneous coronary interven-
ion was performed in 17 patients, whereas the remaining 7
atients underwent coronary artery bypass grafting. The
ecision for revascularization was based on worsening an-
ina and/or the presence of ischemia on noninvasive testing.
redictors of events. Baseline and clinical characteristics
f patients with and without events are described in Table 1.
atients presenting with events during follow-up were
ignificantly older (p  0.03) and had worse clinical
ondition, as indicated by an elevated European System for
ardiac Operative Risk Evaluation value (p  0.01). No
ignificant differences in risk factors for CAD and use of
edication were observed.
Differences in MSCT characteristics of patients with and
ithout events are summarized in Table 2. Patients with
vents had more extensive atherosclerosis on MSCT, as
eflected by a higher coronary calcium score and a higher
umber of segments showing (obstructive) plaques. Also,
elatively more mixed and calcified plaques were observed as
ompared with patients without events.
In Table 3, the univariate analysis of both clinical and
SCT characteristics to predict events is summarized. In
he multivariate analysis (Table 4), MSCT characteristics
hat were significant during univariate analysis were cor-
ected for baseline characteristics with p  0.5 during
nivariate analysis, whereas the type of scanner (16- vs.
4-slice MSCT) used was also included in the analysis. As
ndicated in Table 4, the remaining significant independent
redictors of cardiac events in the multivariate analysis were
he presence of coronary plaques, obstructive CAD, LM/
AD disease, number of coronary segments with plaques,
umber of coronary segments with obstructive plaques, and
umber of coronary segments with mixed plaques.
ultivariate Predictors of Events,orrected for Baseline Variables
Table 4 Multivariate Predictors of Events,Corrected for Baseline Variables
MSCT Characteristics Multivariate p Value
Presence of coronary plaques on MSCT 8.8 (1.1–70) 0.04
Obstructive CAD 28 (3.3–239) 0.002
Obstructive CAD in LM/LAD 35 (4.3–288) 0.0009
Segments with plaques* 1.3 (1.1–1.6) 0.0009
Segments with obstructive plaques* 1.8 (1.5–2.2) 0.0001
Segments with mixed plaques* 1.6 (1.2–2.0) 0.0003ata are Cox’s proportional hazard ratios (95% confidence intervals). *Ratio per segment.
Abbreviations as in Tables 1 and 3.
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January 2/9, 2007:62–70 Prognostic Value of MSCT Coronary Angiographyurvival analysis. Kaplan-Meier survival curves are pro-
ided in Figures 2 to 5. As can be derived from Figure 2, no
vents occurred in patients with normal coronary arteries on
SCT, whereas a first-year event rate (including all events)
f 30% was observed in patients with any CAD on MSCT
log-rank p value  0.005). Excluding revascularizations
esulted in a first-year hard cardiac event rate of 5% in
atients with CAD on MSCT, as compared with 0% in
atients with completely absent CAD on MSCT (log-rank
value  0.19) (Fig. 3).
In Figure 4, the relationship between the severity of CAD
nd the occurrence of events was further explored, showing an
ncreased event rate in patients with obstructive CAD (63%)
ompared with patients without CAD (0%) or nonobstructive
Figure 2 Kaplan-Meier Curves for All Events in Patients With N
All events indicate cardiac death, nonfatal infarction, unstable angina requiring ho
Figure 3 Kaplan-Meier Curves for Hard Cardiac Events in Patie
Hard cardiac events indicate cardiac death, nonfatal infarction, and unstable anginAD (8%) (log-rank p value 0.001). Finally, LM/LAD
isease was found to be associated with the highest event rate
77%), as shown in Figure 5 (log-rank p value 0.001).
iscussion
n the present study, MSCT coronary angiography provided
ndependent prognostic information for predicting cardiac
vents. Patients with completely absent CAD on MSCT
oronary angiography had an excellent prognosis (0% event
ate), whereas an increased event rate (30%) was observed in
atients with CAD on MSCT. Furthermore, the risk of
ardiac events increased with the extent of CAD as observed
n MSCT, and patients with obstructive lesions (particularly
l and Abnormal Coronary Arteries on MSCT
ation, and revascularization. MSCT  multislice computed tomography.
ith Normal and Abnormal Coronary Arteries on MSCT
iring hospitalization. MSCT  multislice computed tomography.orma
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Prognostic Value of MSCT Coronary Angiography January 2/9, 2007:62–70n the LM and LAD) were shown to be at the greatest risk for
ardiac events. Even after correction for baseline clinical variables
uch as age and risk factors, MSCT variables reflecting coronary
laque burden, including the severity, extent, and location of
therosclerosis, remained independent predictors of cardiac events.
The prognostication and subsequent management of
atients with known or suspected CAD in current practice
elies on initial clinical evaluation, with the low-risk patients
eing reassured and the high-risk patients being referred for
nvasive angiography (14). However, the majority of these
atients are in the intermediate risk group, in whom
Figure 4 Kaplan-Meier Curves for All Events in Patients With N
Coronary Arteries, Nonobstructive CAD, and Obstructi
All events indicate cardiac death, nonfatal infarction, unstable angina requiring ho
CAD  coronary artery disease; MSCT  multislice computed tomography.
Figure 5 Kaplan-Meier Curves for All Events in Patients With N
Without Obstructive CAD in LM/LAD, and Patients W
All events indicate cardiac death, nonfatal infarction, unstable angina requiring ho
LAD  left anterior descending coronary artery; LM  left main coronary artery; otrognosis and subsequent management is less well defined.
ccordingly, these patients need additional testing with 1 or
ore of the established noninvasive modalities, which
nclude exercise electrocardiography, stress SPECT imag-
ng, or stress echocardiography (14). All these techniques
im at detecting ischemia. Exercise electrocardiography is
ot an ideal modality because of the suboptimal accuracy,
nd imaging of stress-induced perfusion abnormalities or
ystolic wall motion abnormalities may be preferred; indeed,
verage sensitivity and specificity of 87% and 73% to detect
AD have been reported for SPECT versus 82% and 84%
l
D on MSCT
ation, and revascularization.
l Coronary Arteries, Patients
structive CAD in LM and/or LAD on MSCT
ation, and revascularization.
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January 2/9, 2007:62–70 Prognostic Value of MSCT Coronary Angiographyor stress echocardiography (15,16). In addition, these tests
roved to be predictive of future cardiac events when
bnormalities were found and were associated with a low
isk for events when the test results were normal (17–19).
Multislice computed tomography coronary angiography
s a highly accurate, noninvasive imaging technique for the
iagnosis of CAD; in particular, the negative predictive
alue of MSCT approaches 100%, allowing CAD to be
uled out (20,21).
The current study explored the prognostic value of
SCT in a symptomatic patient population with known or
uspected CAD and a high prevalence of conventional risk
actors. Consequently, the pretest likelihood of CAD was
igh in this population, and even in patients without known
isease, CAD was present on MSCT in 69%. Not surpris-
ngly, therefore, high cardiac event rates were observed.
ost importantly, however, a 100% event-free survival was
oted in patients without any abnormalities on MSCT,
ighlighting an excellent negative predictive value of a
ormal MSCT. This finding is of major clinical relevance,
ecause these patients may indeed be safely reassured
ithout need for further testing. Patients with coronary
therosclerosis identified on MSCT were shown to have a
orse prognosis. More detailed analysis showed that al-
hough the risk of events was considerably higher in patients
ith obstructive CAD, patients with nonobstructive CAD
till were at elevated risk as compared with patients without
AD. Indeed, previous studies support the notion that
laque composition (in addition to stenosis severity) is
redictive of events. Moreover, Mann et al. (22) showed in
postmortem study that lipid core size and minimal cap
hickness, 2 major determinants of plaque vulnerability,
ere not related to absolute plaque size or degree of stenosis.
ccordingly, vulnerable plaques may occur across the full
pectrum of severity of stenosis, underlining that also
onobstructive lesions may contribute to coronary events
23,24). Because less obstructive plaques are more frequent
han severely obstructive plaques, coronary occlusion and
yocardial infarction may in fact most frequently arise from
ild to moderate stenoses (23,25–28). Pooling of these
ngiographic studies showed that 68% of myocardial infarc-
ions were attributable to so-called “angiographically silent”
esions (luminal narrowing 50%), whereas only 14% could
e assigned to a severe stenotic lesion (70%) (29). In line
ith these observations, multivariate analysis of the possible
redictors of cardiac events in the present study showed that
onobstructive CAD was indeed an independent predictor
f future cardiac events. Of interest, the presence of mixed
laques, which may represent less advanced and possibly less
tabilized atherosclerosis as compared with dense calcified
esions (30), was shown to be an independent predictor as
ell. However, further investigations are clearly needed to
upport these observations.
Nonetheless, considering individual lesions, the likeli-
ood of progression to coronary occlusion (and subsequent
yocardial infarction) remains highest for severe obstructiveesions (23,25,26). Indeed, prospective evaluation of nonby-
assed coronary segments, as was performed in the CASS
Coronary Artery Surgery Study), showed that during a
-year follow-up only 0.7% and 2.3% of segments with
arrowing of respectively 5% and 5% to 49% resulted in
oronary occlusion (25). In contrast, occlusion occurred in
0.1% and even 23.6% of lesions with narrowing 50% to
0% and 81% to 95%, respectively. In agreement, high event
ates were observed for patients with obstructive CAD in
he present study. More detailed analysis showed that
azard ratios were highest for patients with obstructive
AD in either the LM or LAD coronary arteries. Indeed
revious studies showed that patients with severe proximal
AD disease are at high risk (31–33); for example, Califf
t al. (34) reported a 59% event-free survival at 5 years in
atients with 3-vessel disease and proximal LAD disease.
ccordingly, early identification of these patients with
SCT will be crucial to optimize therapy.
tudy limitations. The prognostic value of MSCT in the
resent study was evaluated in patients presenting with a
ide spectrum of different conditions, including patients
ith no previous history of CAD and patients with previous
yocardial infarction and revascularization. Accordingly,
reatment strategies may have differed substantially within
he studied population, and future studies will need to
ddress the prognostic role of MSCT coronary angiography
n more homogeneous patient populations. Also, the study
opulation was small, and some clinically relevant predictors
ay not have reached statistical significance. Studies in
arger cohorts (with longer follow-up) are clearly warranted
o confirm these initial results.
onclusions. This is the first study to show the indepen-
ent prognostic value of MSCT coronary angiography over
aseline clinical risk factors in patients presenting with chest
ain. An excellent prognosis (0% event rate) was noted in
atients with a normal MSCT. The presence of CAD
either nonobstructive or obstructive atherosclerotic lesions)
as associated with an event rate of 30%. The event rate was
ighest in the presence of obstructive lesions and when
esions were located in the LM/LAD coronary arteries.
uture studies are needed to further define the prognostic
alue of MSCT.
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